Based on the current research and our previous investigations showing that effective inhibition of PRC2 catalytic activity can be achieved by blocking either EED or EZH2 in different models of AKI,21, 22 we suggest that pharmacologically targeting PRC2 may be a novel approach to treat AKI induced by various insults. Here, EED is linked to acute kidney injury.